Published in J Cardiovasc Electrophysiol on November 01, 1997
Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation (2004) 4.13
Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. Am J Physiol Heart Circ Physiol (2007) 2.28
Drug-induced torsades de pointes and implications for drug development. J Cardiovasc Electrophysiol (2004) 2.05
Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation. Heart Rhythm (2008) 1.96
Potent antiarrhythmic effects of chronic amiodarone in canine pulmonary vein sleeve preparations. J Cardiovasc Electrophysiol (2009) 1.78
Clinical and genetic determinants of torsade de pointes risk. Circulation (2012) 1.67
Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes. Heart Rhythm (2005) 1.63
Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes. Europace (2007) 1.57
Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations. J Am Coll Cardiol (2011) 1.55
Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting. Pharmacotherapy (2012) 1.46
Heterogeneity and cardiac arrhythmias: an overview. Heart Rhythm (2007) 1.41
Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone. Br J Pharmacol (2001) 1.30
Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone. Cardiovasc Res (2007) 1.15
Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria. Circ Arrhythm Electrophysiol (2009) 1.13
Ionic mechanisms for electrical heterogeneity between rabbit Purkinje fiber and ventricular cells. Biophys J (2010) 1.11
Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts. Br J Pharmacol (2008) 0.97
Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome. J Am Coll Cardiol (2008) 0.97
Drug-induced spatial dispersion of repolarization. Cardiol J (2008) 0.94
The role of late I Na in development of cardiac arrhythmias. Handb Exp Pharmacol (2014) 0.93
Effects of the gap junction uncoupler palmitoleic acid on the activation and repolarization wavefronts in isolated rabbit hearts. Br J Pharmacol (1999) 0.90
Relevance of anaesthesia for dofetilide-induced torsades de pointes in alpha1-adrenoceptor-stimulated rabbits. Br J Pharmacol (2007) 0.89
Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel. Circ Res (2011) 0.84
Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves. J Pharmacol Exp Ther (2010) 0.81
The virtual ventricular wall: a tool for exploring cardiac propagation and arrhythmogenesis. J Biol Phys (2006) 0.76
Electrophysiological mechanisms of long and short QT syndromes. Int J Cardiol Heart Vasc (2016) 0.75
Pulmonary Vein Sleeves as a Pharmacologic Model for the Study of Atrial Fibrillation. Electrofisiol Arritm (2010) 0.75
Ranolazine versus amiodarone for prevention of postoperative atrial fibrillation. Future Cardiol (2011) 0.75
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26
Cellular basis for the electrocardiographic J wave. Circulation (1996) 5.25
Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation (1999) 5.04
Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res (1999) 4.57
Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation (1998) 4.13
Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation (2000) 3.99
Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol (1976) 3.62
Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J (2002) 3.01
Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle. Circ Res (1993) 2.59
The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol (1999) 2.56
Early repolarization syndrome: clinical characteristics and possible cellular and ionic mechanisms. J Electrocardiol (2000) 2.54
Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ Res (1988) 2.49
Characteristics and distribution of M cells in arterially perfused canine left ventricular wedge preparations. Circulation (1998) 2.48
Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol (2000) 2.42
Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo: torsades de pointes develops with halothane but not pentobarbital anesthesia. J Cardiovasc Electrophysiol (2000) 2.38
Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle. Am J Physiol Heart Circ Physiol (2001) 2.27
Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation (1997) 2.20
Electrotonic modulation of the T wave and cardiac memory. Am J Cardiol (1982) 2.18
Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de Pointes in models of acquired and congenital long QT syndrome. J Cardiovasc Electrophysiol (1999) 2.14
Cellular basis for complex T waves and arrhythmic activity following combined I(Kr) and I(Ks) block. J Cardiovasc Electrophysiol (2001) 2.14
A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ Res (1991) 2.14
Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol (2000) 2.08
A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med (2000) 2.02
The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J (2000) 1.92
I(to) and action potential notch are smaller in left vs. right canine ventricular epicardium. Am J Physiol (1996) 1.91
Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am J Cardiol (1974) 1.88
Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands. J Med Chem (2000) 1.85
The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. Cardiovasc Res (2000) 1.70
DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites. Mol Cell Biol (2000) 1.68
Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia. Role of the transient outward current. Circulation (1993) 1.62
Paroxysmal atrioventricular block related to hypopolarization and spontaneous diastolic depolarization. Chest (1973) 1.58
Cellular and ionic basis for T-wave alternans under long-QT conditions. Circulation (1999) 1.55
The role of amino acids in extracellular loops of the human P2Y1 receptor in surface expression and activation processes. J Biol Chem (1999) 1.54
Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. Cardiovasc Res (1996) 1.53
Chromanol 293B inhibits slowly activating delayed rectifier and transient outward currents in canine left ventricular myocytes. J Cardiovasc Electrophysiol (2001) 1.53
The Brugada syndrome: diagnostic criteria and cellular mechanisms. Eur Heart J (2001) 1.50
I(NaCa) contributes to electrical heterogeneity within the canine ventricle. Am J Physiol Heart Circ Physiol (2000) 1.48
Differences in the electrophysiologic response of four canine ventricular cell types to alpha 1-adrenergic agonists. Cardiovasc Res (1999) 1.45
Acceleration-induced action potential prolongation and early afterdepolarizations. J Cardiovasc Electrophysiol (1998) 1.44
Intraventricular trifascicular blocks. The syndrome of right bundle branch block with intermittent left anterior and posterior hemiblock. Am Heart J (1969) 1.43
Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome. Circulation (2000) 1.43
The mechanism of intermittent bundle branch block: relationship to prolonged recovery, hypopolarization and spontaneous diastolic depolarization. Chest (1973) 1.42
Phase resetting and annihilation of pacemaker activity in cardiac tissue. Science (1979) 1.42
Left anterior hemiblock obscuring the diagnosis of right bundle branch block. Circulation (1973) 1.40
Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 reentry? Circulation (1993) 1.38
Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues. Does activation of ATP-regulated potassium current promote phase 2 reentry? Circulation (1993) 1.37
Lipomatous hypertrophy of the atrial septum presenting as a right atrial mass. Am J Surg Pathol (1996) 1.35
Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium. Circulation (1989) 1.32
Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J Med Chem (1998) 1.32
Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome. J Electrocardiol (1999) 1.31
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes. J Med Chem (1998) 1.31
Kinase CK2 inhibition: an update. Curr Med Chem (2013) 1.29
Intraventricular trifascicular blocks. Review of the literature and classification. Am Heart J (1969) 1.28
Characteristics of reflection as a mechanism of reentrant arrhythmias and its relationship to parasystole. Circulation (1980) 1.27
The Brugada syndrome. J Cardiovasc Electrophysiol (1998) 1.25
Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation (2001) 1.23
Distribution of M cells in the canine ventricle. J Cardiovasc Electrophysiol (1994) 1.21
Functionally distinct sodium channels in ventricular epicardial and endocardial cells contribute to a greater sensitivity of the epicardium to electrical depression. Am J Physiol Heart Circ Physiol (2008) 1.15
Rate dependence of action potential duration and refractoriness in canine ventricular endocardium differs from that of epicardium: role of the transient outward current. J Am Coll Cardiol (1989) 1.15
High [Ca2+]o-induced electrical heterogeneity and extrasystolic activity in isolated canine ventricular epicardium. Phase 2 reentry. Circulation (1994) 1.14
Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium. Circ Res (1991) 1.11
Evidence for the presence of M cells in the guinea pig ventricle. J Cardiovasc Electrophysiol (1996) 1.09
Transmural dispersion of repolarization and the T wave. Cardiovasc Res (2001) 1.09
Antibodies to beta-adrenergic receptors disclosing agonist-like properties in idiopathic dilated cardiomyopathy and Chagas' heart disease. J Cardiovasc Electrophysiol (1994) 1.07
Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J Med Chem (1999) 1.07
6-Aminoquinolones as new potential anti-HIV agents. J Med Chem (2000) 1.05
Right bundle branch block with left anterior hemiblock surgically induced in tetralogy of Fallot. Relation to the mechanism of electrocardiographic changes in endocardial cushion defects. Am J Cardiol (1970) 1.05
Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): standardised reporting for model reproducibility, interoperability, and data sharing. Prog Biophys Mol Biol (2011) 1.03
Five cases of intermittent left anterior hemiblock. Am J Cardiol (1969) 1.02
Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery. Curr Med Chem (2010) 1.02
Sympathetic modulation of the long QT syndrome. Eur Heart J (2002) 1.01
Divergent expression of delayed rectifier K(+) channel subunits during mouse heart development. Cardiovasc Res (2001) 0.99
The Brugada syndrome: clinical, genetic, cellular, and molecular abnormalities. Am J Med (2001) 0.99
Pacemaker annihilation: diagnostic and therapeutic implications. Am Heart J (1980) 0.98
High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities. J Am Coll Cardiol (1995) 0.98
Wenckebach periods in the bundle branches. Circulation (1969) 0.98
Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome. J Cardiovasc Electrophysiol (1997) 0.97
Wenckebach periods of alternate beats. Clinical and experimental observations. Circulation (1973) 0.97
Block of I(Ks) does not induce early afterdepolarization activity but promotes beta-adrenergic agonist-induced delayed afterdepolarization activity. J Cardiovasc Electrophysiol (2000) 0.96
Supernormal conduction in the accessory pathway of patients with overt or concealed ventricular pre-excitation. J Am Coll Cardiol (1987) 0.94
Abnormal Q waves in right sided chest leads provoked by onset of right bundle-branch block in patients with anteroseptal infarction. Br Heart J (1982) 0.94
Electrotonically mediated delayed conduction and reentry in relation to "slow responses" in mammalian ventricular conducting tissue. Circ Res (1981) 0.93
Sodium effects on 4-aminopyridine-sensitive transient outward current in canine ventricular cells. Am J Physiol (1997) 0.93
Rate dependence and supernormality in excitability of guinea pig papillary muscle. Am J Physiol (1990) 0.92
Chiral resolution and stereospecificity of 6-phenyl-4-phenylethynyl- 1,4-dihydropyridines as selective A(3) adenosine receptor antagonists. J Med Chem (1999) 0.92
Ten years of experience with amiodarone. Am Heart J (1983) 0.92
Electrical heterogeneity, cardiac arrhythmias, and the sodium channel. Circ Res (2000) 0.91
Brugada syndrome: historical perspectives and observations. Eur Heart J (2002) 0.91
The topoisomerase II poison clerocidin alkylates non-paired guanines of DNA: implications for irreversible stimulation of DNA cleavage. Nucleic Acids Res (2001) 0.90
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen. J Med Chem (2000) 0.89
The mechanism of bidirectional tachycardia. Am Heart J (1969) 0.89
Relationships between increased automaticity and depressed conduction in the main intraventricular conducting fascicles of the human and canine heart. Circulation (1974) 0.89
The antifungal antibiotic clotrimazole potently inhibits L-type calcium current in guinea-pig ventricular myocytes. Br J Pharmacol (1999) 0.89
Electrotonic metabolism of pacemaker activity. Further biological and mathematical observations on the behavior of modulated parasystole. Circulation (1982) 0.89
Experimental production of rate-dependent bundle branch block in the canine heart. Circ Res (1974) 0.88
The occurrence of phase-4 block in the anomalous bundle of patients with Wolff-Parkinson-White syndrome. Eur J Cardiol (1975) 0.88